Skip to main content

Peer Review reports

From: Effects of bevacizumab plus irinotecan on response and survival in patients with recurrent malignant glioma: a systematic review and survival-gain analysis

Original Submission
8 Dec 2009 Submitted Original manuscript
8 Feb 2010 Reviewed Reviewer Report - Jeffrey Raizer
13 Feb 2010 Reviewed Reviewer Report - Antonis Valachis
21 Feb 2010 Reviewed Reviewer Report - Patrick Wen
24 Mar 2010 Author responded Author comments - Juxiang Chen
Resubmission - Version 2
24 Mar 2010 Submitted Manuscript version 2
5 Apr 2010 Reviewed Reviewer Report - Jeffrey Raizer
12 Apr 2010 Reviewed Reviewer Report - Antonis Valachis
18 Apr 2010 Reviewed Reviewer Report - Patrick Wen
10 May 2010 Author responded Author comments - Juxiang Chen
Resubmission - Version 3
10 May 2010 Submitted Manuscript version 3
21 May 2010 Author responded Author comments - Juxiang Chen
Resubmission - Version 4
21 May 2010 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
27 May 2010 Author responded Author comments - Juxiang Chen
Resubmission - Version 7
27 May 2010 Submitted Manuscript version 7
Publishing
2 Jun 2010 Editorially accepted
2 Jun 2010 Article published 10.1186/1471-2407-10-252

You can find further information about peer review here.

Back to article page